CARsgen Therapeutics Holdings Limited (2171.HK)
HKD 8.83
(-0.56%)
HKD 8.83
(-0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -454.93 Million | -643.04 Million | -512.32 Million | -295.15 Million | -179 Million |
| Net Income | -747.38 Million | -890.95 Million | -4.73 Billion | -1.06 Billion | -265.13 Million |
| Depreciation & Amortization | 87.39 Million | 81.53 Million | 52.44 Million | 40.1 Million | 19.56 Million |
| Deferred income taxes | 51.42 Million | - | 4.15 Billion | 703.42 Million | 39.7 Million |
| Stock-based compensation | 14.45 Million | 43.99 Million | 13.5 Million | 1.71 Million | 1.92 Million |
| Change in working capital | 211.37 Million | 43.48 Million | 13.37 Million | 13.45 Million | 27.28 Million |
| Other non-cash items | -72.2 Million | 78.89 Million | -6.64 Million | 10.19 Million | -2.35 Million |
| Investing Cash Flow | 39.25 Million | 2.38 Billion | -2.47 Billion | -6.89 Million | 82.98 Million |
| Investments in PPE | -9.54 Million | -138.61 Million | -178.45 Million | -18.73 Million | -103.45 Million |
| Acquisitions | 47.15 Million | - | 2.31 Billion | - | - |
| Investment purchases | -2.03 Billion | -3.48 Billion | -4.75 Billion | - | - |
| Sales/Maturities of investments | 2.03 Billion | 5.92 Billion | 2.44 Billion | - | 170.14 Million |
| Other Investing Activities | 1.64 Million | 82.6 Million | -2.29 Billion | 11.83 Million | 16.3 Million |
| Financing Cash Flow | -22.14 Million | -236.51 Million | 2.67 Billion | 1.3 Billion | 27.52 Million |
| Debt repayment | -4.85 Million | -327.74 Million | -146.86 Million | -157.77 Million | -244.12 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 6.61 Million | 10.5 Million | 2.57 Billion | - | - |
| Other Financing Activities | -303 Thousand | 80.72 Million | 244.81 Million | 1.46 Billion | 271.64 Million |
| Accounts receivables | 3110.00 | -2609.00 | -6543.00 | 364.00 | -2329.00 |
| Accounts payables | - | - | - | - | - |
| Inventory | -683 Thousand | - | - | - | - |
| Other working capital | 212.05 Million | 43.48 Million | 13.38 Million | 13.45 Million | 27.28 Million |
| Cash at beginning of period | 2.26 Billion | 691.28 Million | 1.04 Billion | 96.47 Million | 163.55 Million |
| Cash at end of period | 1.84 Billion | 2.26 Billion | 691.28 Million | 1.04 Billion | 96.47 Million |
| Capital Expenditure | -9.54 Million | -138.61 Million | -178.45 Million | -18.73 Million | -103.45 Million |
| Effect of forex changes on cash | 19.54 Million | 69.32 Million | -42.07 Million | -53.93 Million | 1.41 Million |
| Net cash flow / Change in cash | -418.28 Million | 1.57 Billion | -351.68 Million | 946.49 Million | -67.07 Million |
| Free Cash Flow | -464.48 Million | -781.66 Million | -690.77 Million | -313.88 Million | -282.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -175.77 Million | -175.77 Million | -171.66 Million | -747.38 Million | -171.66 Thousand | -202.23 Thousand |
| Depreciation & Amortization | 20.84 Million | 20.84 Million | 21.67 Million | 87.39 Million | 21.1 Thousand | 21.48 Thousand |
| Deferred income taxes | - | - | - | 51.42 Million | - | - |
| Stock-based compensation | 4.59 Million | 4.59 Million | -2.14 Million | 14.45 Million | -2144.00 | 9373.00 |
| Change in working capital | - | - | 2.79 Million | 211.37 Million | 2792.00 | - |
| Other non-cash items | 22.36 Million | 22.36 Million | -7.21 Million | -72.2 Million | -6651.00 | 100.47 Thousand |
| Investing Cash Flow | 3.29 Million | 3.29 Million | 221.88 Million | 39.25 Million | 221.88 Thousand | -202.26 Thousand |
| Investments in PPE | -2.3 Million | -2.3 Million | -408.5 Thousand | -9.54 Million | -408.50 | -4009.00 |
| Acquisitions | - | - | - | 47.15 Million | - | 57.67 Thousand |
| Investment purchases | - | - | - | -2.03 Billion | - | -1.82 Billion |
| Sales/Maturities of investments | - | - | - | 2.03 Billion | - | 1.36 Billion |
| Other Investing Activities | 5.59 Million | 5.59 Million | 222.29 Million | 1.64 Million | 222.29 Thousand | -198.25 Thousand |
| Financing Cash Flow | 12.34 Million | 12.34 Million | -7.31 Million | -22.14 Million | -7319.00 | -3752.00 |
| Debt repayment | - | - | - | -4.85 Million | - | -2.7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -45.9 Million | -45.9 Million | -2215.50 | - | -2215.50 | - |
| Common Stock Issuance | - | - | - | 6.61 Million | - | 5.01 Million |
| Other Financing Activities | 58.24 Million | 58.24 Million | -7.31 Million | -303 Thousand | -7319.00 | -3752.00 |
| Accounts receivables | - | - | 1.55 Million | 3110.00 | 1555.00 | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -341.5 Thousand | -683 Thousand | -341.50 | - |
| Other working capital | - | - | 1.57 Million | 212.05 Million | 1578.50 | - |
| Cash at beginning of period | - | - | -82.81 Million | 2.26 Billion | - | 2.54 Billion |
| Cash at end of period | -98.59 Million | -98.59 Million | 82.9 Thousand | 1.84 Billion | 82.9 Thousand | 1.81 Billion |
| Capital Expenditure | -2.3 Million | -2.3 Million | -408.5 Thousand | -9.54 Million | -408.50 | -4009.00 |
| Effect of forex changes on cash | 13.74 Million | 13.74 Million | 24.89 Million | 19.54 Million | 24.89 Thousand | -15.12 Thousand |
| Net cash flow / Change in cash | -98.59 Million | -98.59 Million | 82.9 Million | -418.28 Million | 82.9 Thousand | -729.76 Million |
| Free Cash Flow | -130.27 Million | -130.27 Million | -156.96 Million | -464.48 Million | -156.96 Thousand | -74.91 Thousand |
ELVG
IFII
017370
4308
VIAAY
MOS